CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
The crackdown on pixel tracking in telehealth is a warning for every startup

From TechCrunch

By Carly Page

April 17, 2023

The crackdown on pixel tracking in telehealth is a warning for every startup

Healthcare startups are scrambling to reassess how their websites and apps are built, and how third parties may, inadvertently or not, be putting patients’ protected health information at risk.

In March, U.S. mental health startup Cerebral admitted it shared the private health information of more than 3 million users with Facebook, Google, TikTok and other ad giants via so-called tracking pixels. These near-invisible bits of code are typically embedded in web pages to share information about users’ activity, often for analytics. Cerebral said these trackers inadvertently collected sensitive user data since it began operating in October 2019.

In its disclosure to the U.S. Department of Health and Human Services (HHS), Cerebral said that following a review of its code, it “determined that it had disclosed certain information that may be regulated as protected health information under [the Health Insurance Portability and Accountability Act],” or HIPAA, as it’s commonly referred to. This information included patients’ phone numbers, IP addresses, insurance information, mental health assessment responses and associated clinical data.

This data lapse is the third-largest breach of health data in 2023, according to the HHS, which is investigating the breach. However, while Cerebral’s lapse ranks among the most serious and damaging, the breach is just one of many currently being investigated by HHS — and this list is likely to grow.

More casualties

Last year, a joint investigation by STAT and The Markup found that dozens of hospital websites and telehealth startups were sharing patients’ medical information with advertisers and tech giants.

The crackdown on pixel tracking in telehealth is a warning for every startup by Carly Page originally published on TechCrunch

Most Recent

AI Companies Play Cat-and-Mouse With Secret-Stealing Spies

From ‘honey pots’ to insider threats, Silicon Valley was on espionage alert even before the FBI's arrest of an OpenAI employee

Oct 15, 2026

He Crafted a Crypto Law for Trump—as His Company Got Millions From a Crypto Giant

Money from Tether flowed to Nxum while Bo Hines worked in the White House on landmark stablecoin legislation.

Oct 15, 2026

Ramp Completes Funding at $60 Billion Value as Revenue Surges

Ramp has surged to $2 billion in annualized revenue, the fintech company plans to announce Thursday — a milestone that's helped attract fresh investor capital.

Oct 15, 2026

TSMC Open to Working With Terafab But Must Control Plants

Taiwan Semiconductor Manufacturing Co. is in discussions about collaborating with Elon Musk's Terafab project …

Oct 15, 2026

Similar Posts

Terry Myerson retires as Truveta CEO, with co-founders stepping in to lead $1B health data startup

Truveta co-founders Jay Nanduri and Ryan Ahern will serve as interim co-CEOs of the health data company, which Myerson helped build from a pandemic-era idea into a business with 500 employees and 30 member health systems.

Sep 15, 2026

Fold Health streamlines admin work for primary care providers

Abhijit Gupta and Ram Sahasranam have plenty of experience in the health tech space, having sold their first startup, health app maker Praxify, to Athenahealth. Now the duo are focused on value-based care. Fold Health is their operating system for cutting down on the amount of admin work performed by value-based providers. Today, the startup […]

Jul 12, 2023

Psychedelics startup Nue Life Health rolls out free version of its ketamine therapy tracking app

Nue Life Health is a U.S.-based telemedicine startup that combines psychedelic-assisted therapies and a health tracking app. Previously, the app was only offered as part of its own internal service. However, the startup is now opening up its “Nue app” and its “Nue score” available for free to any patient undergoing ketamine therapy, not just […]

Jun 15, 2023

Temasek’s Sheares Healthcare backs Asia-focused mental health startup Thoughtfull

Southeast Asia’s mental health startups are getting more investor attention. Last week, Intellect announced a strategic investment from IHH Healthcare, Asia’s largest private healthcare group. Now Thoughtfull, another digital mental health platform focused on Asia, has raised $4 million in a pre-Series A round led by Sheares Healthcare Group. Sheares is a wholly-owned subsidiary of […]

Mar 22, 2023